DIN 02473720 — SYMTUZA 200 MG; 150 MG; 10 MG; 800 MG
SYMTUZA is a tablet of Darunavir / Cobicistat / Emtricitabine / Tenofovir Alafenamide marketed by JANSSEN INC. The full Darunavir / Cobicistat / Emtricitabine / Tenofovir Alafenamide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02473720
- Brand name
- SYMTUZA
- Active ingredient
- Darunavir / Cobicistat / Emtricitabine / Tenofovir Alafenamide
- Strength
- 200 MG; 150 MG; 10 MG; 800 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- JANSSEN INC
- Health Canada status
- MARKETED
- Drug class
- Antiretroviral combination (HIV protease inhibitor, pharmacokinetic enhancer, and nucleos(t)ide reverse transcriptase inhibitors)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.